-
Mashup Score: 8Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review - 2 year(s) ago
Abstract As the clinical applications of immune checkpoint inhibitors (ICIs) expand, our knowledge of the potential adverse effects of these drugs continues to broaden. Emerging evidence supports t…
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 0Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review - 2 year(s) ago
Abstract Immune checkpoint inhibitors (ICIs) are a major class of immuno-oncology therapeutics that have significantly improved the prognosis of various cancers, both in (neo)adjuvant and metastati…
Source: JACC: CardioOncologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The use of immune checkpoint inhibitors for cancer treatment is rapidly growing, with potential implications for #CardioOnc. Learn more about these revolutionary therapies in #JACCCardioOnc and their potential cardiovascular implications. https://t.co/fWnutvTUkM #ImmuneTherapy https://t.co/gU2pHvi4FB
-
-
Mashup Score: 3Cancer Immunotherapy Beyond Checkpoint Blockade: JACC: CardioOncology State-of-the-Art Review - 2 year(s) ago
Abstract Avoidance of immune destruction is recognized as one of the hallmarks of cancer development. Although first predicted as a potential antitumor treatment modality more than 50 years ago, th…
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
🔑 #JACCCardioOnc state-of-the-art review discusses the latest evidence surrounding innovative therapeutic approaches in cancer #immunotherapy beyond checkpoint blockade. Check it out: https://t.co/uZhxL9r0R7 #CardioOnc #CardioTwitter #MedTwitter https://t.co/AqfasZbsb8
-
-
Mashup Score: 14Melanoma Treatment: The Heart Has Skin in the Game∗ - 2 year(s) ago
Corresponding Author
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
Read #JACCardioOnc's editorial regrading #MEK-inhibitor based therapies and #cardiotoxicity. Great insights, but questions remain 👉 https://t.co/11Q6RtnEgT #CardioOnc #MELsm #Melanoma #CardioTwitter @SALLOUMFN
-
-
Mashup Score: 1
Abstract T-cell therapies, such as chimeric antigen receptor (CAR) T-cell, bispecific T-cell engager (BiTE) and tumor-infiltrating lymphocyte (TIL) therapies, fight cancer cells harboring specific …
Source: JACC: CardioOncologyCategories: Cardiologists, Latest HeadlinesTweet-
RT @ApoThera: Cardiotoxicity of T-Cell Antineoplastic Therapies https://t.co/LMFvQkBnAO #oncology #CardioTwitter #MedEd #medicalcare #biote…
-
-
Mashup Score: 2
Abstract Background Trametinib is a MEK1 (mitogen-activated extracellular signal-related kinase kinase 1) inhibitor used in the treatment of BRAF (rapid accelerated fibrosarcoma B-type)–mutated met…
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
Trametinib produces a cardiomyopathy associated with elevated levels of IL-6 and oxidative stress and independent interstitial fibrosis. Learn more in #JACCCardioOnc: https://t.co/s2gGrm0Rf8 #CardioOnc #Trametinib #CardioToxicity #CardioTwitter https://t.co/tpAF4Ekic9
-
-
Mashup Score: 6The Value of Performance Status in Predicting Clinical Outcomes in Patients With Cancer-Associated Pulmonary Embolism∗ : - 2 year(s) ago
Corresponding Author
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
Interesting #JACCCardioOnc editorial discussing the value of the @eaonc performance score in cancer patients with #VTE: https://t.co/tCWyByCCJF #CardioOnc #cvVTE #DVT #CardioTwitter
-
-
Mashup Score: 2Racial Differences in Chronic Stress/Allostatic Load Variation Due to Androgen Deprivation Therapy in Prostate Cancer: - 2 year(s) ago
IntroductionAllostatic load (AL) is a score calculated through biomarkers involving the cardiovascular, metabolic, and inflammatory systems that reflects the cumulative effect of stress caused by adaptation to adverse psychosocial or physical situations.1 Non-Hispanic Blacks (NHBs) have a higher AL burden compared with non-Hispanic Whites (NHWs). A 1-unit increase in AL over a 9.9-year period can…
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
Chronic stress is ⬆️ among non-Hispanic Blacks compared w/ non-Hispanic Whites before a #prostatecancer diagnosis, but both groups experienced a 📈 after diagnosis & Tx w/ ADT. https://t.co/GJS8G5w9UI #JACCCardioOnc #CardioOnc #CardioTwitter
-
-
Mashup Score: 5Cardio-Oncology in Chile: The Future of an Emerging Discipline - 2 year(s) ago
Central Illustration
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
#CardioOnc has arrived in Chile. Read about their amazing work including the establishment of a #cardiooncology rehab program for cancer patients and survivors: https://t.co/rmII4nWxIx #JACCCardioOnc #CVD #CardioTwitter https://t.co/wo4hIQsiIa
-
-
Mashup Score: 1Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review - 2 year(s) ago
Abstract As the clinical applications of immune checkpoint inhibitors (ICIs) expand, our knowledge of the potential adverse effects of these drugs continues to broaden. Emerging evidence supports t…
Source: JACC: CardioOncologyCategories: Cardiologists, Latest HeadlinesTweet-
Reviewing the evidence linking immune checkpoint inhibitor therapy with atherosclerotic cardiovascular disease https://t.co/XKhgagbhXY @JACCJournals #JACCCardioOnc by @GiselleSA_MDPhD M. Zanni @TomasNeilan https://t.co/M6RXS9GZoh
-
🚨 #JACCCardioOnc SOTA review on the effect of immune checkpoint inhibitor on progression of #ASCVD ♦️In-depth overview of the pre-clinical & clinical evidence ♦️Insights on Dx & pharmacological approaches https://t.co/UsCG4e8vEG #CardioOnc @GiselleSA_MDPhD @TomasNeilan https://t.co/cdEdtpKZHR